Vaginal infections in patients of childbearing age: ways for optimization of treatment in the outpatient setting

Abstract

Despite the considerable success in managing the medical process and medical screening of women of childbearing age, the treatment of vaginal infection remains an urgent problem that requires periodic correction of the prescribed therapy. This made the authors conduct a study, which was aimed at investigating the optimization aspects of the comprehensive therapy regimens for vaginal infections (VI) that combine the use of etiotropic drugs with the extract of Aloe Barbadenis Multi-Gyn ActiGel and systemic enzyme therapy as compared to the prescription of monotherapeutic etiotropic regimen. The study evaluated the effectiveness of different treatment regimens of VIs based on the dynamics of clinical and laboratory parameters, as well as the safety and tolerability of different therapies based on the registration of adverse events.Based on the study results, we would advise to include the plant extract of Aloe Barbadenis Multi-Gyn ActiGel and Wobenzym into the therapy of patients with VIs induced by the  vaginal dysbiosis and caused by bacterial vaginosis and candidiasis vulvovaginitis-associated microorganisms to improve the elimination of the pathogen and provide a normal titre of lactobacilli with preservation of their functional activity, which eventually restores the impaired vaginal microcenosis and maintains a normal vaginal flora and simultaneously provides a high safety and good tolerability of the proposed treatment regimen.